Lunai Bioworks LNAI
NASDAQ LNAI
$1.77 -0.07 (-3.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Share-based Compensation (2016 - 2026)

Updated

Lunai Bioworks (LNAI) recorded Share-based Compensation of $168,993 in fiscal Q3 2026 (quarter ended Mar 31, 2026), down 88.7% from $1.5 million a year earlier but up 31.2% from the prior quarter.

Analysis

Lunai Bioworks (LNAI) Share-based Compensation (2016 - 2026) Analysis & Trends

On a TTM basis, Lunai Bioworks' Share-based Compensation came in at $1.38 million as of Mar 31, 2026, down 57.6% year-over-year; for FY2025 (ended Jun 30, 2025), it came in at $3.31 million, down 29.1% from FY2024.

  • Annual Share-based Compensation has a five-year compound annual growth rate of 26.4% (FY2020 to FY2025).
  • Across earlier fiscal years, Share-based Compensation came in at $4.67 million in FY2024 (+32.2%), $3.54 million in FY2023 (-35.6%), $5.49 million in FY2022 (+280.0%) and $1.44 million in FY2021 (+40.4%).
  • Quarterly Share-based Compensation has ranged from $128,819 in fiscal Q2 2026 to $2.73 million in fiscal Q1 2022 over the past five years.
  • On a year-over-year basis, Share-based Compensation has declined for three consecutive quarters, with an average decline of 37.3% over the last eight quarters.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 736.4% in fiscal Q1 2022, against a decline of 88.7% in fiscal Q3 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $128,819 (Q2 2026), $181,312 (Q1 2026) and $897,813 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Lunai Bioworks 5.81 Mn 1.06 Mn 20,942.00 168,993.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 168,993.00
Dec 31, 2025 128,819.00
Sep 30, 2025 181,312.00
Jun 30, 2025 897,813.00
Mar 31, 2025 1.50 Mn
Dec 31, 2024 558,631.00
Sep 30, 2024 357,648.00
Jun 30, 2024 828,471.00
Mar 31, 2024 1.86 Mn
Dec 31, 2023 999,228.00
Sep 30, 2023 983,829.00
Jun 30, 2023 612,885.00
Mar 31, 2023 1.08 Mn
Dec 31, 2022 819,955.00
Sep 30, 2022 1.03 Mn
Jun 30, 2022 141,659.00
Mar 31, 2022 577,676.00
Dec 31, 2021 2.04 Mn
Sep 30, 2021 2.73 Mn
Jun 30, 2021 259,823.00
API Access

Lunai Bioworks Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LNAI&period=max&api_key=YOUR_API_KEY